Chinese tech, pharma firms eye Hong Kong as springboard for global expansion
Mainland Chinese technology and pharmaceutical companies are using Hong Kong as a launching pad for global expansion, industry leaders have said, as a major state-owned drugmaker weighs whether to invest in the city’s Northern Metropolis megaproject. The comments highlighting the city’s international background and professional expertise were made during a six-day trip to the rest of the Greater…
Chinese tech and pharmaceutical companies are leveraging Hong Kong as a springboard for global expansion, according to industry leaders. During a six-day trip to the Greater Bay Area, they lauded the city's international background, professional expertise, and unique cultural blend as key advantages. Chen Jiehui, vice-chairman of Guangzhou Pharmaceutical Holdings, highlighted the city's potential to help traditional Chinese medicine go global, noting its role as a platform for leveraging international standards.
The Northern Metropolis megaproject, aimed at transforming 30,000 hectares of land near the mainland border into a technological and economic hub, has attracted interest from state-owned pharmaceutical enterprises. Wang Yuemiao, executive dean of PCI Technology Group, emphasized Hong Kong's mature international business network and professional services as crucial for helping mainland enterprises efficiently engage overseas.
EHang's vice-president, Xue Peng, suggested that the city's numerous islands and cross-border logistics capabilities could be harnessed for aerial drone transport applications, initially tested in designated areas before broader expansion. Hong Kong's government has established a GoGlobal Task Force to support mainland enterprises in going global, aligning with the bay area strategy and the Belt and Road Initiative.
Written by urgent.news from South China Morning Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
